🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes

RecruitingNAAges 45 Years - 75 YearsFemaleUniversity of Alberta
NCT05188027 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One will be a moderate aerobic exercise session (30 minutes of exercise, 60 minutes of recovery), and the third will be a moderate weight-lifting session (\~30 minutes of exercise, 60 minutes of recovery).The investigators will measure changes in blood glucose during exercise by drawing blood during and after exercise. Post-exercise glucose trends will be examined using continuous glucose monitoring.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * type 1 diabetes, diagnosed for at least one year * post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy * able to perform aerobic and resistance exercise * able to visit the lab in Edmonton, Alberta (University of Alberta) Exclusion Criteria: * HbA1c \> 9.9 % * frequent and unpredictable hypoglycemia * change in insulin management strategy within the last 2 months * blood pressure \> 140 / 95 * severe peripheral neuropathy * history of cardiovascular disease * musculoskeletal injuries interfering with exercise performance * use of medications (other than insulin) that affect glucose metabolism * BMI \> 30 kg/m2 * smoking * moderate to high alcohol intake (\> 2 drinks/day)
💊

What it tests

  • Aerobic Exercise
  • Resistance Exercise
  • No exercise
📍

Where

2 sites
Alberta Diabetes Institute
Edmonton, Canada
Institut de recherches cliniques de Montréal
Montreal, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy